Early research (Phase 1)Study completedNCT02834611What this trial is testingCeramide NanoLiposome in Patients With Advanced Solid TumorsWho this might be right forCancerCarcinomaSolid Tumors+1 more Keystone Nano, Inc 14
Not applicableNot Yet RecruitingNCT07689812What this trial is testingRandomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.Who this might be right forNSCLC (Advanced Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Carcinoma)+12 more Natera, Inc. 920
Testing effectiveness (Phase 2)Active Not RecruitingNCT03647163What this trial is testingPh I/II Trial of Systemic VSV-IFNβ-NIS in Combination With Checkpoint Inhibitor Therapy in Patients With Select Solid TumorsWho this might be right forSolid TumorNon Small Cell Lung CancerNeuroendocrine Carcinoma+1 more Vyriad, Inc. 33
Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Testing effectiveness (Phase 2)Looking for participantsNCT03556228What this trial is testingVMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or LymphomaWho this might be right forHead and Neck CarcinomaAdenoid Cystic CarcinomaLung Cancer+22 more VM Oncology, LLC 242
Early research (Phase 1)Study completedNCT04811898What this trial is testingA Dose Escalation Study of LNA-i-Mir-221 for Cancer TreatmentWho this might be right forMultiple Myeloma, RefractoryHepatocarcinomaAdvanced Solid Tumor Azienda Ospedaliera Universitaria Mater Domini, Catanzaro 17
Testing effectiveness (Phase 2)Looking for participantsNCT06128551What this trial is testingStudy of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid TumorsWho this might be right forNon-Small Cell Lung Cancer (NSCLC)Colorectal CancerPancreatic Ductal Adenocarcinoma Revolution Medicines, Inc. 534
Testing effectiveness (Phase 2)Ended earlyNCT01832857What this trial is testingPhase 2 Safety, Tolerability and Efficacy Study of CPI-613 in Cancer PatientsWho this might be right forCancer Cornerstone Pharmaceuticals 7
Early research (Phase 1)Study completedNCT03000257What this trial is testingBudigalimab (ABBV-181) in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors AbbVie 182
Early research (Phase 1)Active Not RecruitingNCT06147037What this trial is testingA Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid TumoursWho this might be right forAdvanced Solid TumorMetastatic Colorectal CarcinomaHead and Neck Squamous Cell Carcinoma+4 more AstraZeneca 13
Very early researchUnknownNCT05961111What this trial is testingA Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid TumorsWho this might be right forSarcomaCarcinomaDigestive Cancer+7 more Shanghai Yunying Medical Technology 20
Early research (Phase 1)UnknownNCT02977364What this trial is testingA Trial of C-met Kinase Inhibitor HS-10241 in Subjects With Advanced Solid TumoursWho this might be right forCarcinomaSolid Tumor, Adult Jiangsu Hansoh Pharmaceutical Co., Ltd. 50
Not applicableStudy completedNCT04593277What this trial is testingInteractive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA StudyWho this might be right forClinical Stage I Cutaneous Melanoma AJCC v8Clinical Stage II Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Melanoma AJCC v8+13 more Fred Hutchinson Cancer Center 549
Early research (Phase 1)UnknownNCT05780307What this trial is testingIMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorNon-small Cell Lung CancerSmall Cell Lung Cancer+3 more ImmuneOnco Biopharmaceuticals (Shanghai) Inc. 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT04291105What this trial is testingPhase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer PatientsWho this might be right forMelanomaHead and Neck Squamous Cell CarcinomaColo-rectal Cancer Vyriad, Inc. 87
Testing effectiveness (Phase 2)Active Not RecruitingNCT04165330What this trial is testingEvaluation of AL3818 in Combination With Nivolumab in Solid TumorsWho this might be right forSolid Tumor, AdultSoft Tissue SarcomaNon Small Cell Lung Cancer+1 more Sarcoma Oncology Research Center, LLC 56
Early research (Phase 1)Study completedNCT00413075What this trial is testingStudy of Oral PXD101 in Patients With Advanced Solid Tumors or LymphomaWho this might be right forSolid TumorLymphoma Valerio Therapeutics 121
Early research (Phase 1)Study completedNCT00045175What this trial is testingUCN-01 and Topotecan in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity CancerWho this might be right forFallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer University Health Network, Toronto 33
Testing effectiveness (Phase 2)Ended earlyNCT00923247What this trial is testingA Targeted Phase I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade ), in Adults With Solid Tumors With a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroid Cancer (MTC)Who this might be right forMedullary Thyroid Carcinoma National Cancer Institute (NCI) 22
Testing effectiveness (Phase 2)Looking for participantsNCT07488676What this trial is testingASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid TumorsWho this might be right forGastric or Gastro-esophageal Junction (GEJ) AdenocarcinomaPancreatic Adenocarcinoma Astellas Pharma Global Development, Inc. 150